NCT02663323 - Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 2, 2016

Primary Completion Date

October 5, 2017

Study Completion Date

July 5, 2020

Conditions

Coronary Artery Disease

Interventions

DEVICE

MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System

MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System in the treatment of de-novo coronary artery lesions.

Trial Locations (4)

University Clinic of Cardiology, Skopje

Medistra Hospital, Jakarta

Institut Jantung Negara, Kuala Lumpur

Instituto Dante Pazzanese de Cardiologia, São Paulo